Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 28Phase 3 21Phase 1/2 18Phase 4 9Phase NA 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 19INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 43Gastrointestinal 39Lymphoid 32Other hematologic neoplasm 27Thoracic 20Plasma cell 20Head & Neck 19Breast 18Genitourinary 15Sarcoma 14Dermatologic 14Gynecologic 12CNS 11Tumor-Agnostic 8Myeloid 2Other 1NET 1Endocrine 1Classical hematology 1

Conditions

Neuroendocrine Tumors 1

Interventions

64Cu-SARTATE 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × INDUSTRY × NET × Clear all
NCT04440956 2020-06-22

An Imaging Study of 64Cu-SARTATE Using Positron Emission Tomography in Patients With Neuroendocrine Tumours

Clarity Pharmaceuticals Ltd

Phase EARLY_PHASE1 Completed
10 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡